Results 91 to 100 of about 4,909 (178)

Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Oncological Outcomes and Long-Term Survival among Patients with Gastric Cancer and Limited Peritoneal Disease Progression after Neoadjuvant Chemotherapy. [PDF]

J Clin Med, 2023
Kobiałka S, Sędłak K, Pelc Z, Mlak R, Endo Y, Bogacz P, Kurylcio A, Polkowski WP, Pawlik TM, Rawicz-Pruszyński K.   +9 more
europepmc   +1 more source

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Recurrent Ovarian Carcinoma Management [PDF]

Doctor.Ru, 2020
K.D. Guseinov, I.V. Berlev, A.M. Belyaev, A.F. Urmancheeva, T.V. Gorodnova, G.S. Kireeva, M.G. Yakovleva, M.G. Shikhzadaeva   +7 more
openaire   +1 more source

Advanced local jejunal carcinoma treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a case report and review of the literature. [PDF]

Ann Med Surg (Lond)
Armosh GA, Alnajjar KO, Alaswad M, Azzam AA, Aldeheshi A, Azzam AZ, Alalem I.   +6 more
europepmc   +1 more source

Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). [PDF]

Pleura Peritoneum, 2023
Kartik A, Müller C, Acs M, Piso P, Starlinger P, Bachleitner-Hofmann T, Grotz TE.   +6 more
europepmc   +1 more source

The Role of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal GIST-Induced Sarcomatosis (GISTosis). [PDF]

J Clin Med
Spiliotis J, Kopanakis N, Rogdakis A, Peppas G, Fotiadou A, Evangelou K, Vassos N.   +6 more
europepmc   +1 more source

The evaluation of morbidity in gastrointestinal tumor patients underwent cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC). [PDF]

Turk J Surg, 2023
Aytin YE, Cakcak İE, Sağıroğlu T.
europepmc   +1 more source

Evaluation of the Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on Long-Term Survival and Morbidity Profile: A Systematic Review of the Peritoneal Carcinomatosis Management. [PDF]

Cureus
Sarmiento Bonilla CI, Maldonado J, Paredes Haro HD, González Mercado ZEDA, Dunay Silva AAA, Duran S PX, López Bernal NO, Romero Amaya CC, Baena Manotas AP.   +8 more
europepmc   +1 more source

Simultaneous Surgical Approach with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Concurrent Peritoneal and Liver Metastases of Colon Cancer Origin. [PDF]

J Clin Med, 2023
Morales-Soriano R, Pineño-Flores C, Morón-Canis JM, Molina-Romero FJ, Rodriguez-Pino JC, Loyola-Miró J, Gonzalez-Argente FX, Palma-Zamora E, Guillot-Morales M, Giménez S, Alvarez-Mon M, Ortega MA, Segura-Sampedro JJ.   +12 more
europepmc   +1 more source

Ca125 KELIM as a Potential Tool for Predicting Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Benefit at Interval Cytoreductive Surgery for Advanced Epithelial Ovarian Cancer-A Propensity Score-Matched Analysis. [PDF]

J Surg Oncol
Sinukumar S, Kazi M, Damodaran D, Prabhu A, Piplani S, Naik S, Sankaralingam D, Bhatt A.   +7 more
europepmc   +1 more source

Primary Peritoneal Hepatoid Adenocarcinoma Patients Treated by Complete Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). [PDF]

Indian J Surg Oncol, 2023
Buiron C, Grange R, Rousset P, Villeneuve L, Benzerdjeb N, Glehen O, Kepenekian V.   +6 more
europepmc   +1 more source